Physician profile
Denada Palm
NPI 1053756593
$13,616.23
in general payments reported to CMS, 2019-2025
11 companies · $64.34 in 2025
The $64.34 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,126 · 2020: $11K · 2021: $39.08 · 2022: $164 · 2023: $169 · 2024: $531 · 2025: $64.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $10,570.98 | 2019-2020 | |
| Boston Scientific Corporation | $1,834.48 | 2019 | |
| Shockwave Medical, INC | $343.68 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $326.14 | 2023-2025 | Impella |
| Heartflow, INC. | $135.30 | 2024 | |
| Cardiovascular Systems INC. | $128.23 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $115.38 | 2019 | |
| Inari Medical, INC. | $50.77 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $44.52 | 2023-2024 | Perclose Prostyle, Na |
| Medtronic, INC. | $39.08 | 2021 | |
| Surmodics, INC. | $27.67 | 2025 | Pounce Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Sublime 014 Rx Pta Balloon Dilatation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denada Palm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.